Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Daclatasvir

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 654Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Getting patented meds on NLEM list an uphill battle says committee member
    Getting patented meds on NLEM list an uphill battle says committee member

    15 Sep 2022

    // Teena Thacker ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/getting-patented-meds-on-nlem-list-an-uphill-battle-says-committee-member/articleshow/94213010.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    Teena Thacker ECONOMIC TIMES
    15 Sep 2022
    Share Share
    AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries
    AbbVie inks licensing deal to boost Mavyret access in nearly 100 countries

    14 Nov 2018

    // Eric Sagonowsky FIERCE PHARMA

    https://www.fiercepharma.com/pharma/abbvie-medicines-patent-pool-ink-license-deal-for-hep-c-drug-mavyret-for-nearly-100

    Eric Sagonowsky FIERCE PHARMA
    14 Nov 2018
    Share Share
    List of centrally authorised products requiring a notification of a change for update of annexes
    List of centrally authorised products requiring a notification of a change for update of annexes

    12 Oct 2018

    // EMA

    https://www.ema.europa.eu/documents/regulatory-procedural-guideline/list-centrally-authorised-products-requiring-notification-change-update-annexes_en-0.pdf

    EMA
    12 Oct 2018
    Share Share
    Natco Pharma launches Hepatitis C drug in India
    Natco Pharma launches Hepatitis C drug in India

    03 Jul 2018

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-pharma-launches-hepatitis-c-drug-in-india/articleshow/64825917.cms

    ECONOMIC TIMES
    03 Jul 2018
    Share Share
    Epclusa's fast-tracked Chinese approval might be late for Gilead
    Epclusa's fast-tracked Chinese approval might be late for Gilead

    31 May 2018

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma-asia/gilead-wins-chinese-approval-for-epclusa-but-emerging-market-getting-crowded

    Angus Liu FIERCE PHARMA
    31 May 2018
    Share Share
    Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report
    Opdivo, Repatha and Lynparza likely among China’s 2018 blockbuster nods: report

    06 Jan 2018

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/marketing/opdivo-repatha-and-lynparza-likely-among-china-s-2018-blockbuster-nods-report

    Angus Liu FIERCE PHARMA
    06 Jan 2018
    Share Share